marimastat has been researched along with ro 31-9790 in 2 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (ro 31-9790) | Trials (ro 31-9790) | Recent Studies (post-2010) (ro 31-9790) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 28 | 0 | 0 |
| Protein | Taxonomy | marimastat (IC50) | ro 31-9790 (IC50) |
|---|---|---|---|
| Interstitial collagenase | Homo sapiens (human) | 0.0058 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0074 | |
| Stromelysin-1 | Homo sapiens (human) | 0.47 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.012 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, N; Ikeda, S; Inoue, S; Ohishi, Y; Okada, Y; Tsujishita, H; Yamamoto, M | 1 |
| Barlaam, B; Bird, TG; Campbell, D; Foster, SJ; Lambert-Van Der Brempt, C; Maciewicz, R | 1 |
2 other study(ies) available for marimastat and ro 31-9790
| Article | Year |
|---|---|
Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Topics: Amino Acid Sequence; Dipeptides; Humans; Hydroxamic Acids; Ligands; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Models, Molecular; Mutation; Phenylalanine; Protease Inhibitors; Protein Conformation; Structure-Activity Relationship; Thiophenes | 1998 |
New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.
Topics: ADAM Proteins; ADAM17 Protein; Administration, Oral; Animals; Callithrix; Humans; Hydroxamic Acids; Metalloendopeptidases; Protease Inhibitors; Quinazolines; Succinates; Tumor Necrosis Factor-alpha | 1999 |